liposomal glutathione diabetes Gluthathione LIPOSOMAL GLUTATHIONE
Description
10.1038/srep07532 253 NakaseI

While detailed molecular data for ANX1502 is not yet available, it is currently being evaluated for treating cold agglutinin disease (CAD)

doi: 10.1021/jm991060m

At the definite time points, cells were lysed with RIPA buffer (10 2 M TrisCl (pH 8.0), 10 3 M EDTA, 5 10 4 M EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 0.14 10 3 M NaCl, 1 protease inhibitor cocktail (#P8340), 1 phosphatase inhibitor cocktail 2 and 3 (#P5726, P0044), 10 3 M PMSF (all obtained from Sigma-Aldrich)

PMID: 35620028

Stojanovic A, Martorell L, Montalvo I, Ortega L, Monseny R, Vilella E et al (2014)
